Jupiter Neurosciences, Inc. (JUNS)
2.20
+0.07
(+3.29%)
USD |
NASDAQ |
Nov 06, 16:00
2.01
-0.19
(-8.64%)
After-Hours: 20:00
Jupiter Neurosciences Enterprise Value : 1.716M for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 1.716M |
| November 05, 2026 | 1.670M |
| November 04, 2026 | 1.889M |
| November 03, 2026 | 1.869M |
| November 02, 2026 | 1.789M |
| October 30, 2026 | 1.616M |
| October 29, 2026 | 1.829M |
| October 28, 2026 | 1.916M |
| October 27, 2026 | 2.009M |
| October 26, 2026 | 2.155M |
| October 23, 2026 | 2.235M |
| October 22, 2026 | 1.969M |
| October 21, 2026 | 2.102M |
| October 20, 2026 | 2.115M |
| October 19, 2026 | 2.082M |
| October 16, 2026 | 2.185M |
| October 15, 2026 | 2.341M |
| October 14, 2026 | 2.374M |
| October 13, 2026 | 2.487M |
| October 12, 2026 | 2.274M |
| October 09, 2026 | 2.148M |
| October 08, 2026 | 2.095M |
| October 07, 2026 | 2.142M |
| October 06, 2026 | 2.155M |
| October 05, 2026 | 1.862M |
| Date | Value |
|---|---|
| October 02, 2026 | 1.949M |
| October 01, 2026 | 1.916M |
| September 30, 2026 | 1.876M |
| September 29, 2026 | 1.969M |
| September 28, 2026 | 1.922M |
| September 25, 2026 | 2.028M |
| September 24, 2026 | 2.172M |
| September 23, 2026 | 2.228M |
| September 22, 2026 | 2.235M |
| September 21, 2026 | 2.162M |
| September 18, 2026 | 2.155M |
| September 17, 2026 | 2.254M |
| September 16, 2026 | 2.201M |
| September 15, 2026 | 2.254M |
| September 14, 2026 | 2.520M |
| September 11, 2026 | 2.281M |
| September 10, 2026 | 2.348M |
| September 09, 2026 | 2.308M |
| September 08, 2026 | 2.301M |
| September 04, 2026 | 2.434M |
| September 03, 2026 | 2.421M |
| September 02, 2026 | 2.534M |
| September 01, 2026 | 2.480M |
| August 31, 2026 | 2.607M |
| August 28, 2026 | 3.032M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 692.32B |
| ANI Pharmaceuticals, Inc. | 1.715B |
| Corcept Therapeutics, Inc. | 7.597B |
| Veru, Inc. | 13.04M |
| Eli Lilly & Co. | 1.319T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.274M |
| Revenue (Quarterly) | 0.0242M |
| Total Expenses (Quarterly) | 2.299M |
| EPS Diluted (Quarterly) | -4.079 |
| Gross Profit Margin (Quarterly) | 87.19% |
| Profit Margin (Quarterly) | -9.40K% |
| Earnings Yield | -868.8% |
| Normalized Earnings Yield | -919.74 |